EN
登录

Perspective Therapeutics和其他3只低于1美元的股票内幕人士正在买入

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

benzinga 等信源发布 2023-12-19 08:29

可切换为仅中文


Loading...Loading...The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.Below is a look at a few recent notable insider transactions for penny stocks.

正在加载。。。正在加载。。。道琼斯指数周一收盘小幅上涨。当内幕人士买卖股票时,这表明他们对公司前景的信心或担忧。对低价股感兴趣的投资者和交易员可以在他们的整体投资或交易决策中考虑这一因素。以下是近期几起值得注意的低价股内幕交易。

For more, check out Benzinga's insider transactions platform.Tharimmune .

更多信息,请查看Benzinga的内幕交易平台。塔里穆恩。

The Trade: Tharimmune, Inc. THAR CEO Randy Milby acquired a total of 29,000 shares an average price of $0.50. To acquire these shares, it cost around $14,587.

交易:塔尔首席执行官兰迪·米尔比(RandyMilby)以0.50美元的平均价格共收购了29000股股份。收购这些股票的成本约为14587美元。

What’s Happening: Tharimmune recently announced topline data with TH104, its lead candidate for moderate-to-severe pruritus in chronic liver disease patients.

发生了什么:Tharimmune最近宣布了TH104的topline数据,TH104是慢性肝病患者中度至重度瘙痒症的主要候选者。

What Tharimmune Does: Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases.

Tharimmune做什么:Tharimmune Inc是一家生物技术公司,开发罕见免疫,炎症和肿瘤疾病的候选治疗药物组合。

Perspective Therapeutics

透视疗法

The Trade: Perspective Therapeutics, Inc. CATX Director Lori A Woods acquired a total of 185,200 shares at an average price of $0.27. To acquire these shares, it cost around $49,989.

交易:透视疗法公司(Perspective Therapeutics,Inc.)CATX董事洛里·伍兹(Lori A Woods)以0.27美元的平均价格收购了185200股股票。收购这些股票的成本约为49989美元。

What’s Happening: Perspective Therapeutics recently announced it agreed to fully divest its brachytherapy business.

发生了什么:透视疗法(Perspective Therapeutics)最近宣布同意全面剥离其近距离放射治疗业务。

What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.

透视疗法做什么:透视疗法公司是一家医疗技术和放射性药物公司,开创了全身癌症的各种治疗应用。

Check This Out: Aware And 3 Other Stocks Under $2 Insiders Are Buying Loading...Loading...SHF Holdings

看看这个:Aware和另外3只2美元以下的股票内幕人士正在买入Loading。。。正在加载。。。SHF控股公司

The Trade: SHF Holdings, Inc. SHFS CEO Sundie Seefried acquired a total of 24,700 shares at an average price of $0.96. The insider spent around $23,737 to buy those shares. The company’s Director also bought 15,000 shares of the company.

交易:SHF Holdings,Inc.SHFS首席执行官SundieSeefried以0.96美元的平均价格收购了24700股股票。知情人士花了大约23737美元购买这些股票。公司董事还购买了15000股公司股份。

What’s Happening: On Nov. 14, SHF Hldgs posted a loss for the third quarter.

发生了什么:11月14日,SHF Hldgs公布了第三季度的亏损。

What SHF Holdings Does: SHF Holdings Inc is a financial services provider to cannabis-related businesses.

SHF Holdings的业务:SHF Holdings Inc是大麻相关企业的金融服务提供商。

Dalrada Financial

达拉达金融

The Trade: Dalrada Financial Corporation DFCO CEO Brian Bonar acquired a total of 9,000 shares at an average price of $0.29. The insider spent around $2,616 to buy those shares.

交易:达拉达金融公司DFCO首席执行官布莱恩·博纳尔以0.29美元的平均价格收购了9000股股票。这位知情人士花了大约2616美元购买了这些股票。

What’s Happening: The company’s stock jumped 26% over the past six months.

发生了什么:该公司的股票在过去六个月里上涨了26%。

What Dalrada Financial Does: Dalrada Financial Corp is a United States-based company engaged in providing financial, insurance, benefit, and business process outsourcing products and services to companies.

Dallada Financial的业务:Dallada Financial Corp是一家总部位于美国的公司,致力于为公司提供金融、保险、福利和业务流程外包产品和服务。

Don’t forget to check out our premarket coverage here

别忘了在这里查看我们的上市前报道

Loading...Loading...

正在加载。。。正在加载。。。